Results

еНаука >  Резултати >  Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes
Назив: Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes
Аутори: Xochelli, Aliki; Baliakas, Panagiotis; Kavakiotis, Ioannis; Agathangelidis, Andreas; Sutton, Lesley-Ann; Minga, Eva; Ntoufa, Stavroula; Tausch, Eugen; Yan, Xiao-Jie; Shanafelt, Tait;
Година: 2017
Публикација: Clinical Cancer Research
ISSN: 1078-0432 Clinical Cancer Research Претражи идентификатор
Издавач: Denville, NJ : The Association
Тип резултата: Научни чланак
Колација: vol. 23 br. 17 str. 5292-5301
DOI: 10.1158/1078-0432.ccr-16-3100
WoS-ID: 000409037300034
Scopus-ID: 2-s2.0-85029456308
PMID: 28536306
URI: https://enauka.gov.rs/handle/123456789/166765
https://imagine.imgge.bg.ac.rs/handle/123456789/1017
https://imagine.imgge.bg.ac.rs/handle/123456789/1611
URL: https://aacrjournals.org/clincancerres/article/23/17/5292/122592/Chronic-Lymphocytic-Leukemia-with-Mutated-IGHV4-34
Пројекат: H "AEGLE, An analytics framework for integrated and personalized healthcare services in Europe", by the EU
H project "MEDGENET, Medical Genomics and Epigenomics Network" by the EU [692298]
Swedish Cancer Society
Swedish Research Council
Uppsala University
Uppsala University Hospital
Lion's Cancer Research Foundation
Selander's Foundation, Uppsala
Associazione Italiana per la Ricerca sul Cancro, Milano, Italy [IG15189, 9965, 10007]
Ricerca Finalizzata [RF-2010-2318823]
Ministero della Salute, Roma, Italy [RF-2011-02349712]
MEYS CZ project NPUII - CEITEC [LQ1601]
Novo Nordisk Fonden [NNF16OC0019302] Funding Source: researchfish
The Danish Cancer Society [R130-A8217] Funding Source: researchfish
Извор метаподатака: Migracija
М-категорија: 
21aM21a - Водећи међународни часопис категорије M21a

36
SCOPUSTM
19
PubMed CentralTM
20
OpenCitations
31
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.